Literature DB >> 4650843

Better influenza vaccines?

.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4650843      PMCID: PMC1786040     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Association of serum anti-neuraminidase antibody with resistance to influenza in man.

Authors:  B R Murphy; J A Kasel; R M Chanock
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

2.  Studies with avian influenza A viruses: cross protection experiments in chickens.

Authors:  W H Allan; C R Madeley; A P Kendal
Journal:  J Gen Virol       Date:  1971-08       Impact factor: 3.891

3.  Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals.

Authors:  J L Schulman; E D Kilbourne
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

4.  Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines.

Authors:  A N Slepushkin; G C Schild; A S Beare; S Chinn; D A Tyrrell
Journal:  J Hyg (Lond)       Date:  1971-12

5.  The polypeptide composition of influenza A viruses.

Authors:  J J Skehel; G C Schild
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

6.  Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.

Authors:  J L Schulman; M Khakpour; E D Kilbourne
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

7.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

8.  Recombinant influenza-A viruses as live vaccines for man. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines.

Authors:  A S Beare; T S Hall
Journal:  Lancet       Date:  1971-12-11       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.